Skip to main content

History

ED treatment attempts dating back to over 1,000 years. People of Ancient Rome and Greece wore rooster and goat genitalia talismans in the 8th century, claiming these talismans would double as aphrodisiacs and encourage sexual function. Albertus Magnus advocated consumption of roasted wolf penis as a cure for impotence during the 13th century. 

Male impotence was considered a felony in France during the late 16th and 17th centuries, as were legal reasons for a divorce. The custom, which included court expert examination of the claimants, was ruled obscene in 1677.

Vincent Marie Mondat invented the first efficient vacuum erection apparatus, or penis pump, in the early 1800s. In the 1970s Geddings Osbon, a Pentecostal preacher, created a more sophisticated system, built on a bicycle pump. He got FDA clearance in 1982 to market the drug as the ErecAid ®. 

In the 1920s and 1930s, John R. Brinkley launched a boom in US male impotence remedies. His radio programmes, including operations by surgeon Serge Voronoff, recommended expensive goat gland implants and "mercurochrome" injections as the path to restored manly virility.

Current ED drug treatment made considerable strides in 1983, when British physiologist Giles Brindley dropped his pants and showed his papaverine-induced erection to a stunned Urodynamics Society audience. The Brindley drug injected into his penis was a non-specific vasodilator, an alpha-blocking agent, and the mechanism of action was simply body-smooth relaxation of the muscles. The effect discovered by Brindley laid the groundwork for the later development of unique, safe, and orally effective drug therapies. 

In 1999 Pfizer launched the new first-line treatment for ED, the oral PDE5 inhibitor.

Comments

Popular posts from this blog

Lexicology

The Latin word impotentia coeundi defines basic inability to insert the penis into the vagina; it is now replaced often by more general terms, such as erectile dysfunction (ED). In medicine, the study of ED is protected by andrology, a sub-field of urology. Research indicates that ED is normal and it is estimated that at least sometimes approximately 40 percent of males experience ED-compatible symptoms.[48] The disorder is also often referred to as phallic impotence.[49] Priapism is its antonym, or opposite state

Pathophysiology

Penile erection is controlled by two mechanisms: the reflex erection achieved by rubbing the penile shaft directly, and the psychogenic erection achieved by sexual or emotional stimulation. The former includes the peripheral nerves and the lower portions of the spinal cord, while the latter contains the brain's limbic network. In both cases a successful and complete erection requires an intact neural system. Stimulation of the penile shaft by the nervous system contributes to nitric oxide (NO) secretion, which induces relaxation of the smooth muscles of the corpora cavernosa (the penis' main erectile tissue), and consequently penile erection. Furthermore, the maintenance of a healthy erectile system requires sufficient amounts of testosterone (producted by the testes) and an intact pituitary gland. Impotence can develop due to hormonal dysfunction, neural system disorders, lack of sufficient supply of penile blood or psychological issues, as can be seen from the mechanisms of a...

Symptoms

ED is defined by the frequent or persistent failure to obtain or sustain adequate rigidity erection to perform sexual activity. It is described as the "persistent or recurring inability to achieve and maintain sufficient rigidity in a penile erection to allow for satisfactory sexual activity for at least 3 months."  Psychological influence  Sometimes ED affects both men and their partners' emotional well-being. Many people do not seek treatment because they feel ashamed. Around 75% of diagnosed ED cases go untreated.